Antisense antiviral compound and method for treating influenza viral infection

Details for Australian Patent Application No. 2010319314 (hide)

Owner AVI BioPharma, Inc.

Inventors Iversen, Patrick L.

Agent Davies Collison Cave

Pub. Number AU-A-2010319314

PCT Pub. Number WO2011/060320

Priority 61/377,382 26.08.10 US; 61/261,278 13.11.09 US; 61/292,056 04.01.10 US

Filing date 12 November 2010

Wipo publication date 19 May 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/060320 Priority application(s): WO2011/060320

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319318-Assessment of topographic semimeridian parameters for corneal astigmatism analysis and vector planning treatment

2010319306-Controlled randomized porous structures and methods for making same